Endometriosis Trial: Study of NBI-56418 in Endometriosis

NCT00109512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: NBI-56418 (GnRH antagonist)
DRUG: placebo

Sponsor

Abbott